NIPER Hajipur signed an MoU with Boehringer Ingelheim India to advance pharmaceutical research collaboration and innovation.
Boehringer will provide access to its opnMe® open science platform for wider scientific exchange and healthcare innovation.
The partnership aims to build research capacity, provide student training, and generate early-stage proof-of-concept data for therapies.
Collaboration seeks to translate scientific discoveries into viable therapies and strengthen India's innovation-driven healthcare ecosystem.